Schedule 13G ownership disclosure
LEGEND BIOTECH CORP
ADR · CUSIP: 52490G102
Event date: 2024-12-31
- Filing-level shares
- 6,808,023
- Percent of class
- 3.7%
- T. Rowe Price Associates, Inc.
Shares: 6,808,023 · Class: 3.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-25-000207
- Form type
- SCHEDULE 13G/A
- Filer
- Legend Biotech Corp
- CIK
- CIK 1801198
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership